|
Volumn 29, Issue 5, 2003, Pages 477-483
|
Botulinum toxin type A treatment for contouring of the lower face
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BOTULINUM TOXIN A;
ADULT;
ARTICLE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
COMPUTER ASSISTED TOMOGRAPHY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CONVALESCENCE;
DOSE RESPONSE;
DRUG ACTIVITY;
DRUG MECHANISM;
ECHOGRAPHY;
ESTHETICS;
FACE ASYMMETRY;
FACE SURGERY;
FEMALE;
FOLLOW UP;
HUMAN;
INJECTION SITE;
MALE;
MANDIBLE;
MASSETER MUSCLE;
MASTICATION;
MUSCLE HYPERTROPHY;
MYALGIA;
PATIENT SATISFACTION;
PRIORITY JOURNAL;
PROSPECTIVE STUDY;
QUANTITATIVE ANALYSIS;
SIDE EFFECT;
SPEECH DISORDER;
TREATMENT INDICATION;
TREATMENT OUTCOME;
ZYGOMA;
ADULT;
BOTULINUM TOXIN TYPE A;
FACE;
FEMALE;
HUMANS;
HYPERTROPHY;
MALE;
MASSETER MUSCLE;
MIDDLE AGED;
NEUROMUSCULAR AGENTS;
PROSPECTIVE STUDIES;
TOMOGRAPHY, X-RAY COMPUTED;
|
EID: 0038286286
PISSN: 10760512
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1524-4725.2003.29116.x Document Type: Article |
Times cited : (140)
|
References (10)
|